Excerpt: Lawmakers in both chambers of Congress and on both sides of the aisle agree that cybersecurity is of critical importance to America’s safety and prosperity in the 21st century. The House of Representatives has already passed the Cyber Intelligence Sharing and Protection Act (CISPA) to bring the nation’s considerable wealth of public and private sector intelligence to bear on the challenge of securing America’s vital communications networks.
Excerpt: The Committee shares the goals of the Commission to ensure the nation’s energy infrastructure is protected from physical and cyber threats and we look forward to learning more about the objectives of the OEIS. To read the letter, click here.
Excerpt: The federal government currently supports energy-related technologies, projects, and companies through various forms of federal assistance, including grants, direct loans, loan guarantees, and a range of available tax credits. Federal dollars also are used to advance programmatic activities, such as implementation of the federal energy mandates.
Excerpt: Abound was the fifth stimulus-funded loan guarantee issued under Section 1705 of the Energy Policy Act of 2005, as amended by the American Recovery and Reinvestment Act (ARRA). Just nine months after the closing of a $400 million loan guarantee in December 2010, DOE stopped funding the project.
The bipartisan leadership of the Energy and Commerce Committee and its Communications and Technology Subcommittee today released data submitted by the Federal Communications Commission regarding the Universal Service Fund high-cost and low-income support programs. The data was supplied by the FCC in response to a request by the committee regarding USF support payments.
Excerpt: The committee has a long bipartisan history of conducting drug safety oversight and is very concerned about these recent developments. We intend to learn more from the FDA, CDC, and others who may provide insight into the details surrounding this outbreak and the prevention of future outbreaks. To read the letter to FDA, click here.